Inari Medical Stock Beneish M Score

NARI Stock  USD 51.92  0.89  1.74%   
This module uses fundamental data of Inari Medical to approximate the value of its Beneish M Score. Inari Medical M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Inari Medical Piotroski F Score and Inari Medical Altman Z Score analysis.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.
  
As of now, Inari Medical's Cash Flow To Debt Ratio is increasing as compared to previous years. As of now, Inari Medical's Free Cash Flow Yield is increasing as compared to previous years. The Inari Medical's current Operating Cash Flow Per Share is estimated to increase to 0.66, while Price To Sales Ratio is projected to decrease to 7.09.
At this time, it appears that Inari Medical is an unlikely manipulator. The earnings manipulation may begin if Inari Medical's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Inari Medical executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Inari Medical's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-3.24
Beneish M Score - Unlikely Manipulator
Elasticity of Receivables

1.11

Focus
Asset Quality

1.07

Focus
Expense Coverage

1.01

Focus
Gross Margin Strengs

0.8

Focus
Accruals Factor

1.01

Focus
Depreciation Resistance

1.0

Focus
Net Sales Growth

0.5

Focus
Financial Leverage Condition

1.0

Focus

Inari Medical Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Inari Medical's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables39 M70.1 M
Way Down
Slightly volatile
Total Revenue247.8 M493.6 M
Way Down
Slightly volatile
Total Assets707.9 M674.2 M
Sufficiently Up
Slightly volatile
Total Current Assets215.4 M235.6 M
Significantly Down
Slightly volatile
Non Current Assets Total460.6 M438.7 M
Sufficiently Up
Slightly volatile
Property Plant Equipment87.4 M83.2 M
Sufficiently Up
Slightly volatile
Depreciation And Amortization11.3 M10.7 M
Sufficiently Up
Slightly volatile
Selling General Administrative177.6 M349.5 M
Way Down
Slightly volatile
Total Current Liabilities80.2 M76.3 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total139.6 M133 M
Sufficiently Up
Pretty Stable
Short Term Debt2.8 M3.4 M
Significantly Down
Slightly volatile
Long Term Debt16.1 M22.4 M
Way Down
Slightly volatile
Short Term Investments131 M76.9 M
Way Up
Slightly volatile
Gross Profit Margin0.70.8803
Significantly Down
Pretty Stable

Inari Medical Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Inari Medical's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Inari Medical in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Inari Medical's degree of accounting gimmicks and manipulations.

About Inari Medical Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation And Amortization

11.27 Million

As of now, Inari Medical's Depreciation And Amortization is increasing as compared to previous years.

Inari Medical Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Inari Medical. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201920202021202220232024 (projected)
Net Receivables11.3M28.0M42.4M58.6M70.1M39.0M
Total Revenue51.1M139.7M277.0M383.5M493.6M247.8M
Total Assets44.5M214.1M311.5M504.2M674.2M707.9M
Total Current Assets39.4M205.7M245.2M422.9M235.6M215.4M
Non Current Assets Total5.1M8.4M66.3M81.2M438.7M460.6M
Property Plant Equipment3.3M7.5M16.5M72.4M83.2M87.4M
Depreciation And Amortization497.5K1.5M4.5M7.6M10.7M11.3M
Selling General Administrative37.2M89.4M190.0M291.9M349.5M177.6M
Total Current Liabilities8.9M13.8M42.5M56.2M76.3M80.2M
Non Current Liabilities Total74.8M3.0M29.8M31.0M133.0M139.6M
Net Debt(4.2M)(114.2M)(63.5M)(27.9M)(6.6M)(6.9M)
Operating Income801.5K18.4M6.7M(28.1M)(14.0M)(13.3M)
Total Cash From Operating Activities(4.9M)1.9M25.5M(14.0M)35.9M37.7M

Inari Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Inari Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Inari Medical's managers, analysts, and investors.
Environmental
Governance
Social

About Inari Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Inari Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inari Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inari Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:
Check out Inari Medical Piotroski F Score and Inari Medical Altman Z Score analysis.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.84)
Earnings Share
(1.35)
Revenue Per Share
9.901
Quarterly Revenue Growth
0.214
Return On Assets
(0.03)
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.